Table 7.
Significance (p) of Tukey–Kramer HSD post hoc tests of differences between groups of patients with multiple sclerosis (pwMS) and control groups (Con) in the present and previous research and their means and standard deviations.
| Present Research | Lobentanz et al. [31] | Ma et al. [32] | Pinar et al. [33] | |||||
|---|---|---|---|---|---|---|---|---|
| pwMS | Con | pwMS | Con | pwMS | Con | |||
| n | 388 | 991 | 231 | 265 | 50 | 50 | ||
| n | M | 7.00 (3.900) |
4.55 (3.710) |
8.90 (5.200) |
5.80 (4.800) |
7.90 (3.500) |
6.02 (3.220) |
|
| (SD) | ||||||||
| M (SD) | ||||||||
| pwMS | 87 | 7.36 (4.678) | 0.996 | 0.000 ** | 0.052 | 0.041 * | 0.995 | 0.583 |
| Con | 134 | 5.60 (3.100) | 0.014 * | 0.090 | 0.000 ** | 1.000 | 0.015 * | 0.999 |
Note. * p < 0.05. ** p < 0.01.